FR4645M - - Google Patents

Info

Publication number
FR4645M
FR4645M FR25864A FR25864A FR4645M FR 4645 M FR4645 M FR 4645M FR 25864 A FR25864 A FR 25864A FR 25864 A FR25864 A FR 25864A FR 4645 M FR4645 M FR 4645M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR25864A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR4645M publication Critical patent/FR4645M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
FR25864A 1964-07-23 1965-07-23 Expired FR4645M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4213264 1964-07-23

Publications (1)

Publication Number Publication Date
FR4645M true FR4645M (fr) 1966-12-05

Family

ID=12627395

Family Applications (1)

Application Number Title Priority Date Filing Date
FR25864A Expired FR4645M (fr) 1964-07-23 1965-07-23

Country Status (4)

Country Link
US (1) US3308120A (fr)
FR (1) FR4645M (fr)
GB (1) GB1073933A (fr)
SE (1) SE366758B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948903A (en) * 1972-12-15 1976-04-06 Parke, Davis & Company Substituted N-(1,2-dihydro-2-oxonicotinyl)-cephalexins and -cephaloglycins
JPS5759862A (en) * 1980-09-29 1982-04-10 Kotobuki Seiyaku Kk Novel pyprolidonecarboxylic acid derivative, antiulcer agent containing said compound, and its preparation

Also Published As

Publication number Publication date
DE1545836B2 (de) 1975-10-09
GB1073933A (en) 1967-06-28
DE1545836A1 (de) 1969-12-11
US3308120A (en) 1967-03-07
SE366758B (fr) 1974-05-06

Similar Documents

Publication Publication Date Title
SE366758B (fr)
BE655281A (fr)
BE432268A (fr)
BE47396A (fr)
BE483969A (fr)
BE507097A (fr)
BE518974A (fr)
BE554195A (fr)
BE564626A (fr)
BE584699A (fr)
BE603534A (fr)
BE610935A (fr)
BE613833A (fr)
BE621510A (fr)
BE622126A (fr)
BE623398A (fr)
BE626083A (fr)
BE626684A (fr)
BE627057A (fr)
BE627390A (fr)
BE627931A (fr)
BE628611A (fr)
BE629793A (fr)
BE632875A (fr)
BE636791A (fr)